Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.59 |
| ▸ | CA2 | P00918 | 2/20 | 0.59 |
| ▸ | CA9 | Q16790 | 2/20 | 0.59 |
| ▸ | CA12 | O43570 | 1/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | CA4 | P22748 | 1/20 | 0.56 |
| ▸ | ATM | Q13315 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | S100A4 | P26447 | 2/20 | 0.53 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | PTPRC | P08575 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30050782 | 1.00 | CA1 (0.59) | CA1CA2CA9CA12TDP1 | |
| SCHEMBL9394327 | 0.91 | S100A4 (0.58) | CA1CA2CA9CA12TDP1 | |
| SCHEMBL9397083 | 0.91 | S100A4 (0.54) | CA1CA2CA9CA12TDP1 | |
| SCHEMBL8091427 | 0.88 | CA1 (0.60) | CA1CA2CA9CA12TDP1 | |
| SCHEMBL8090181 | 0.85 | CA1 (0.58) | CA1CA2CA9CA12TDP1 | |
| SCHEMBL11314968 | 0.84 | CA1 (0.63) | CA1CA2CA9CA12TDP1 | |
| SCHEMBL6961551 | 0.84 | CA1 (0.59) | CA1CA2CA9CA12TDP1 | |
| SCHEMBL29217854 | 0.84 | CA1 (0.55) | CA1CA2CA9CA12TDP1 | |
| SCHEMBL8090169 | 0.83 | POLB (0.58) | CA1CA2CA9CA12TDP1 | |
| SCHEMBL11307275 | 0.83 | POLB (0.64) | CA1CA2CA9CA12TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119504556-A | Bisphenol phthaloyl Process for producing imine | 潍坊弘润石化科技有限公司 | 2025-02-25 | — | — | CN | claimed |
| CN-119504556-A | Bisphenol phthaloyl Process for producing imine | 潍坊弘润石化科技有限公司 | 2025-02-25 | — | — | CN | disclosed |
| CN-114349678-B | Continuous industrial production method of N-alkyl-nitrophthalimide | 珠海派锐尔新材料有限公司 | 2024-04-26 | — | — | CN | disclosed |
| CN-116903517-A | Preparation method of 4-nitro-N-alkylphthalimide | 广东优巨先进新材料股份有限公司 | 2023-10-20 | — | — | CN | disclosed |
| CN-114349678-A | Continuous industrial production method of N-alkyl-nitrophthalimide | 珠海派锐尔新材料有限公司 | 2022-04-15 | — | — | CN | disclosed |
| US-20110263540-A1 | SMALL-MOLECULE INHIBITORS OF PROTEIN SYNTHESIS INACTIVATING TOXINS | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH | 2011-10-27 | — | — | US | disclosed |
| US-20100010060-A1 | Isoindolin-1-One-, Isoindolin-3-One- and Isoindolin-1,3-Dione-Derivatives and Use Thereof | BAYER HEALTHCARE AG (DE) | 2010-01-14 | — | — | US | disclosed |
| WO-2009118596-A2 | PHTHALIMIDE DERIVATIVES AS TRPA1 MODULATORS | GLENMARK PHARMACEUTICALS, S. A. (CH) | 2009-10-01 | — | — | WO | disclosed |
| US-7244847-B2 | Benzimidazole compounds | ISIS PHARMACEUTICALS, INC. (US) | 2007-07-17 | — | — | US | disclosed |
| US-4506083-A | INITIATORS FOR PHOTOPOLYMERIZATION OR PHOTOCHEMICAL CROSSLINKING | CIBA-GEIGY CORPORATION (US) | 1985-03-19 | — | — | US | disclosed |
| US-4505794-A | PHOTOINITIATORS WITH AMINES FOR PHOTOPOLYMERIZATION OF UNSATURATEDCOMPOUNDS; SOLUBILITY | CIBA-GEIGY CORPORATION (US) | 1985-03-19 | — | — | US | disclosed |
| US-4324719-A | YELLOW TO BLUE SHADES ON NYLON CARPET | EASTMAN KODAK COMPANY (US) | 1982-04-13 | — | — | US | disclosed |
| US-4039522-A | Phthalimidyl-azo-m-acylamido-n-substituted aniline compounds and polyester fibers dyed therewith | EASTMAN KODAK COMPANY (US) | 1977-08-02 | — | — | US | disclosed |
| US-4012372-A | MONOAZO DISPERSE DYES | EASTMAN KODAK COMPANY (US) | 1977-03-15 | — | — | US | disclosed |
| US-3980634-A | Phthalimidyl-azo aniline type compounds and polyester fibers dyed therewith | EASTMAN KODAK COMPANY (US) | 1976-09-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110263540-A1 | SMALL-MOLECULE INHIBITORS OF PROTEIN SYNTHESIS INACTIVATING TOXINS | MRPS27, MRPS22, MRPS23 | CA1 3560/4885CA2 3955/4885CA9 4617/4885 |
| US-20100010060-A1 | Isoindolin-1-One-, Isoindolin-3-One- and Isoindolin-1,3-Dione-Derivatives and Use Thereof | ICAM1, SERPINC1, TFPI2 | CA1 4613/4885CA2 4238/4885CA9 4780/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.